Your browser doesn't support javascript.
loading
Serum pro-surfactant protein B is correlated with clinical properties in osteosarcoma patients.
Feng, Shi; Fu, Di; Zhang, Yong; Zhang, Le; Ji, Yingnan; Li, Hongqiu; A, Liang.
Affiliation
  • Feng S; Department of Second Orthopedics, Affiliated Central Hospital of Shenyang Medical College, Shenyang Tiexi District China.
  • Fu D; Department of General Medicine, Affiliated Central Hospital of Shenyang Medical College, Shenyang Tiexi District China.
  • Zhang Y; Department of Second Orthopedics, Affiliated Central Hospital of Shenyang Medical College, Shenyang Tiexi District China.
  • Zhang L; Department of Second Orthopedics, Affiliated Central Hospital of Shenyang Medical College, Shenyang Tiexi District China.
  • Ji Y; Department of Second Orthopedics, Affiliated Central Hospital of Shenyang Medical College, Shenyang Tiexi District China.
  • Li H; Department of Second Orthopedics, Affiliated Central Hospital of Shenyang Medical College, Shenyang Tiexi District China.
  • A L; Department of Second Orthopedics, Affiliated Central Hospital of Shenyang Medical College, Shenyang Tiexi District China.
Biochem Cell Biol ; 101(5): 456-463, 2023 10 01.
Article in En | MEDLINE | ID: mdl-37192548
ABSTRACT
It is critical to find efficient non-invasive prognostic factor for osteosarcoma. In this study, we demonstrated that serum protein of pro-surfactant protein B (pro-SFTPB) may be a potential diagnostic indicator in osteosarcoma. We found that serum pro-SFTPB was highly expressed in osteosarcoma patients and presented good diagnostic value to discern osteosarcoma patients from non-osteosarcoma control subjects. Serum pro-SFTPB was also significantly correlated with advanced clinical stage, distant metastasis, and shorter overall survival. In addition, serum pro-SFTPB was demonstrated to be an independent prognostic factor for osteosarcoma. Overall, our study demonstrated that serum pro-SFTPB may be a useful diagnostic factor for osteosarcoma.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Bone Neoplasms / Osteosarcoma Type of study: Prognostic_studies Limits: Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Bone Neoplasms / Osteosarcoma Type of study: Prognostic_studies Limits: Humans Language: En Year: 2023 Type: Article